Search
for
Sort by
Research 181–210 of 1000+
- Ketoconazole use in the treatment of ovarian hyperandrogenism
- Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry
- Cutaneous hyperandrogenism: role of antiandrogen therapy in acne, hirsutism, and androgenetic alopecia.
- The efficacy of oral isotretinoin versus cyproterone compound in female patients with acne and the triad of cutaneous hyperandrogenism: A randomized clinical trial
- “Who and how to screen for endogenous hypercortisolism among young women presenting with clinical hyperandrogenism and/or menstrual abnormalities ”
- Is There Any Association Between Clinical and Biochemical Hyperandrogenism in Women With Female Pattern Hair Loss?
- O-11 DIAGNOSTIC CHALLENGES IN POSTMENOPAUSAL HYPERANDROGENISM: REPORTS OF TWO CASES
- Secondary Amenorrhea and Clinical Hyperandrogenism in a 34-Year-Old Female: Polycystic Ovary Syndrome or Not?
- 5116 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 5116 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 6450 Leydig Cell Tumor: A Rare Cause of Post-menopausal Hyperandrogenism
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- COMPARING THE EFFECTIVENESS OF ORAL ISOTRETINOIN AND CYPROTERONE COMPOUND IN ACNE TREATMENT AMONG ADULT FEMALES WITH CUTANEOUS HYPERANDROGENISM: A PROSPECTIVE STUDY.
- An Updated Clinico-investigative Approach to Diagnosis of Cutaneous Hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists
- DIAGNOSTIC AND THERAPEUTIC UTILITY OF GONADOTROPHIN-RELEASING HORMONE AGONIST IN POSTMENOPAUSAL HYPERANDROGENISM OF OVARIAN ORIGIN
- Post Menopausal Hyperandrogenism: A Case of a Steroid Cell Tumor of the Ovary
- SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Postmenopausal ovarian hyperandrogenism of surgically treated patients: a case report and scoping review with individual patient’s data analysis
- Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome
- Clinical Pregnancy and Miscarriage Rates in relation to Vitamin D Supplementation among women with Hyper Androgenic PCOS: A prospective study.
- Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
- MON-218 Inflammatory Role of Sex Steroids in Hidradenitis Suppurativa: An Androgenic Phenotype
- Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women
- The modern management of hirsutism
- The Relationship between Serum Levels of Anti-Mullerian Hormone and Body Mass Index in Adolescents with Polycystic Ovary Syndrome
- Androgen-Related Alopecia and Infertility: Impact of Lifestyle Modifications
- MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome